Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer

Zahida Qamri, Anju Preet, Mohd W. Nasser, +4

Molecular Cancer Therapeutics

The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis

Olga Catalina-Rodriguez, Vamsi Krishna Kolukula, York Tomita, +8

Oncotarget

Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo

Anju Preet, Ramesh K. Ganju, Jerome E. Groopman

Oncogene

Tumor BiologyMedicineCancer Cell BiologyRadiation OncologyCancer Biology +4

Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non–Small Cell Lung Cancer Growth and Metastasis

Anju Preet, Zahida Qamri, Mohd W. Nasser, +5

Cancer Prevention Research

Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes

Sanjukta Ghosh, Anju Preet, Jerome E. Groopman, +1

Molecular Immunology

Cannabis UseT-regulatory CellImmune RegulationImmunologyNeuropharmacology +7

Dietary downregulation of mutant p53 levels via glucose restriction

Olga Rodriguez, Sujatra Choudhury, Vamsi Krishna Kolukula, +8

Cell Cycle

NutritionMitophagyCell DeathMetabolic RemodelingCaloric Restriction +19

Slit-2 Induces a Tumor-suppressive Effect by Regulating β-Catenin in Breast Cancer Cells

Anil Prasad, Vikram Paruchuri, Anju Preet, +2

Journal of Biological Chemistry

SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker

Vamsi Krishna Kolukula, Geetaram Sahu, Anton Wellstein, +7

Oncotarget

Tissue and Serum microRNAs in the KrasG12D Transgenic Animal Model and in Patients with Pancreatic Cancer

Joseph J. LaConti, Narayan Shivapurkar, Anju Preet, +6

PLoS ONE

Dissecting the pathways that destabilize mutant p53: The proteasome or autophagy?

Sujata Choundhury, Vamsi Krishna Kolukula, Anju Preet, +2

Cell Cycle

MitophagyApoptosisProteasomeMolecular BiologyCell Death +14